106 related articles for article (PubMed ID: 15655042)
1. Treatment of hepatitis D.
Niro GA; Rosina F; Rizzetto M
J Viral Hepat; 2005 Jan; 12(1):2-9. PubMed ID: 15655042
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis D.
Farci P; Chessa L; Balestrieri C; Serra G; Lai ME
J Viral Hepat; 2007 Nov; 14 Suppl 1():58-63. PubMed ID: 17958644
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis delta: immunopathogenesis and clinical challenges.
Grabowski J; Wedemeyer H
Dig Dis; 2010; 28(1):133-8. PubMed ID: 20460901
[TBL] [Abstract][Full Text] [Related]
4. Advances in hepatitis D virus biology and disease.
Smedile A; Rizzetto M; Gerin JL
Prog Liver Dis; 1994; 12():157-75. PubMed ID: 7746872
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
6. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients.
Le Gal F; Gordien E; Affolabi D; Hanslik T; Alloui C; Dény P; Gault E
J Clin Microbiol; 2005 May; 43(5):2363-9. PubMed ID: 15872267
[TBL] [Abstract][Full Text] [Related]
7. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
8. Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study.
Marzano A; Ottobrelli A; Spezia C; Daziano E; Soranzo ML; Rizzetto M
Ital J Gastroenterol; 1992; 24(3):119-21. PubMed ID: 1562748
[TBL] [Abstract][Full Text] [Related]
9. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
10. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
Niro GA; Ciancio A; Tillman HL; Lagget M; Olivero A; Perri F; Fontana R; Little N; Campbell F; Smedile A; Manns MP; Andriulli A; Rizzetto M
Aliment Pharmacol Ther; 2005 Aug; 22(3):227-32. PubMed ID: 16091060
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
[TBL] [Abstract][Full Text] [Related]
13. [Update hepatitis D].
Erhardt A; Starke C; Loerke J; Giesecke C; Heintges T; Häussinger D
Med Klin (Munich); 2006 Mar; 101 Suppl 1():127-34. PubMed ID: 16802537
[TBL] [Abstract][Full Text] [Related]
14. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
Liaw YF
Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon.
Yurdaydin C; Bozkaya H; Onder FO; Sentürk H; Karaaslan H; Akdoğan M; Cetinkaya H; Erden E; Erkan-Esin O; Yalçin K; Bozdayi AM; Schinazi RF; Gerin JL; Uzunalimoğlu O; Ozden A
J Viral Hepat; 2008 Apr; 15(4):314-21. PubMed ID: 18307594
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic modalities in hepatitis C: challenges and development.
Moreno-Otero R
J Viral Hepat; 2005 Jan; 12(1):10-9. PubMed ID: 15655043
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B in children: complexities in management.
Kerkar N
Pediatr Transplant; 2005 Oct; 9(5):685-91. PubMed ID: 16176431
[TBL] [Abstract][Full Text] [Related]
19. Alpha interferon plus thymopentine in treatment of HBV and/or HDV positive patients undergoing liver transplant.
Gaeta A; Mancini C; Bachetoni A; Sallusto F; Lorino G; Marinucci G; Di Giacomo C; Favalli C; Alfani D; Filadoro F
J Biol Regul Homeost Agents; 1990; 4(2):51-6. PubMed ID: 2260503
[TBL] [Abstract][Full Text] [Related]
20. A practical guide to the use of interferons in the management of hepatitis virus infections.
Saracco G; Rizzetto M
Drugs; 1997 Jan; 53(1):74-85. PubMed ID: 9010649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
